25 XP   0   0   10

Biotricity Inc
Buy, Hold or Sell?

Let's analyse Biotricity together

PenkeI guess you are interested in Biotricity Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotricity Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biotricity Inc

I send you an email if I find something interesting about Biotricity Inc.

Quick analysis of Biotricity (30 sec.)










What can you expect buying and holding a share of Biotricity? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
44.4%

What is your share worth?

Current worth
$-2.89
Expected worth in 1 year
$-4.10
How sure are you?
27.8%

+ What do you gain per year?

Total Gains per Share
$-1.21
Return On Investment
-93.2%

For what price can you sell your share?

Current Price per Share
$1.30
Expected price per share
$1.12 - $1.9
How sure are you?
50%

1. Valuation of Biotricity (5 min.)




Live pricePrice per Share (EOD)

$1.30

Intrinsic Value Per Share

$-1.00 - $-0.66

Total Value Per Share

$-3.89 - $-3.55

2. Growth of Biotricity (5 min.)




Is Biotricity growing?

Current yearPrevious yearGrowGrow %
How rich?-$26.7m-$7.5m-$16.2m-68.2%

How much money is Biotricity making?

Current yearPrevious yearGrowGrow %
Making money-$3.6m-$5.1m$1.4m40.1%
Net Profit Margin-126.4%-225.8%--

How much money comes from the company's main activities?

3. Financial Health of Biotricity (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#328 / 334

Most Revenue
#232 / 334

Most Profit
#199 / 334

Most Efficient
#255 / 334

What can you expect buying and holding a share of Biotricity? (5 min.)

Welcome investor! Biotricity's management wants to use your money to grow the business. In return you get a share of Biotricity.

What can you expect buying and holding a share of Biotricity?

First you should know what it really means to hold a share of Biotricity. And how you can make/lose money.

Speculation

The Price per Share of Biotricity is $1.3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotricity.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotricity, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-2.89. Based on the TTM, the Book Value Change Per Share is $-0.30 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.48 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotricity.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.30-23.3%-0.39-30.3%-0.43-32.7%-0.43-32.9%-0.32-24.4%
Usd Book Value Change Per Share-0.14-10.4%-0.30-23.4%-0.48-37.0%-0.14-10.7%-0.08-6.2%
Usd Dividend Per Share0.000.1%0.000.0%0.021.4%0.011.0%0.010.6%
Usd Total Gains Per Share-0.14-10.4%-0.30-23.3%-0.46-35.6%-0.13-9.8%-0.07-5.6%
Usd Price Per Share1.15-1.10-1.32-1.46-1.74-
Price to Earnings Ratio-0.95--0.74--1.57--1.16--2.01-
Price-to-Total Gains Ratio-8.52--5.20--5.04--1.56-3.06-
Price to Book Ratio-0.40--0.41--15.72--4.63-16.97-
Price-to-Total Gains Ratio-8.52--5.20--5.04--1.56-3.06-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.3
Number of shares769
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.30-0.14
Usd Total Gains Per Share-0.30-0.13
Gains per Quarter (769 shares)-233.00-97.52
Gains per Year (769 shares)-932.02-390.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12-934-94240-430-400
24-1868-187480-860-790
36-2802-2806119-1290-1180
48-3736-3738159-1719-1570
510-4670-4670199-2149-1960
612-5604-5602239-2579-2350
714-6538-6534278-3009-2740
816-7472-7466318-3439-3130
918-8406-8398358-3869-3520
1020-9340-9330398-4298-3910

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.036.00.00.0%0.036.00.00.0%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%10.026.00.027.8%10.026.00.027.8%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%16.00.04.080.0%16.00.020.044.4%16.00.020.044.4%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%5.015.00.025.0%10.026.00.027.8%10.026.00.027.8%

Fundamentals of Biotricity

About Biotricity Inc

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Fundamental data was last updated by Penke on 2024-04-11 02:23:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Biotricity Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biotricity earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biotricity to the Medical Devices industry mean.
  • A Net Profit Margin of -94.5% means that $-0.94 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotricity Inc:

  • The MRQ is -94.5%. The company is making a huge loss. -2
  • The TTM is -126.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-94.5%TTM-126.4%+31.9%
TTM-126.4%YOY-225.8%+99.4%
TTM-126.4%5Y-486.1%+359.8%
5Y-486.1%10Y-831.8%+345.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-94.5%-12.4%-82.1%
TTM-126.4%-20.4%-106.0%
YOY-225.8%-14.4%-211.4%
5Y-486.1%-21.3%-464.8%
10Y-831.8%-25.0%-806.8%
1.1.2. Return on Assets

Shows how efficient Biotricity is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotricity to the Medical Devices industry mean.
  • -51.2% Return on Assets means that Biotricity generated $-0.51 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotricity Inc:

  • The MRQ is -51.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -58.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-51.2%TTM-58.1%+7.0%
TTM-58.1%YOY-48.4%-9.8%
TTM-58.1%5Y-125.9%+67.8%
5Y-125.9%10Y-789.9%+664.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-51.2%-4.1%-47.1%
TTM-58.1%-4.7%-53.4%
YOY-48.4%-4.6%-43.8%
5Y-125.9%-4.0%-121.9%
10Y-789.9%-5.2%-784.7%
1.1.3. Return on Equity

Shows how efficient Biotricity is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotricity to the Medical Devices industry mean.
  • 0.0% Return on Equity means Biotricity generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotricity Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-22.3%+22.3%
5Y-22.3%10Y-104.9%+82.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.2%+4.2%
TTM--5.8%+5.8%
YOY--5.5%+5.5%
5Y-22.3%-6.3%-16.0%
10Y-104.9%-7.1%-97.8%

1.2. Operating Efficiency of Biotricity Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biotricity is operating .

  • Measures how much profit Biotricity makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotricity to the Medical Devices industry mean.
  • An Operating Margin of -43.1% means the company generated $-0.43  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotricity Inc:

  • The MRQ is -43.1%. The company is operating very inefficient. -2
  • The TTM is -70.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-43.1%TTM-70.2%+27.1%
TTM-70.2%YOY-197.0%+126.9%
TTM-70.2%5Y-454.6%+384.5%
5Y-454.6%10Y-820.1%+365.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-43.1%-24.3%-18.8%
TTM-70.2%-16.4%-53.8%
YOY-197.0%-14.0%-183.0%
5Y-454.6%-20.4%-434.2%
10Y-820.1%-24.8%-795.3%
1.2.2. Operating Ratio

Measures how efficient Biotricity is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.43 means that the operating costs are $1.43 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biotricity Inc:

  • The MRQ is 1.431. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.693. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.431TTM1.693-0.262
TTM1.693YOY3.128-1.434
TTM1.6935Y5.395-3.702
5Y5.39510Y8.713-3.318
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4311.456-0.025
TTM1.6931.439+0.254
YOY3.1281.431+1.697
5Y5.3951.436+3.959
10Y8.7131.374+7.339

1.3. Liquidity of Biotricity Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biotricity is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.21 means the company has $0.21 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotricity Inc:

  • The MRQ is 0.211. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.304. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.211TTM0.304-0.093
TTM0.304YOY2.123-1.819
TTM0.3045Y1.005-0.701
5Y1.00510Y0.807+0.198
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2112.693-2.482
TTM0.3042.697-2.393
YOY2.1233.504-1.381
5Y1.0053.617-2.612
10Y0.8073.499-2.692
1.3.2. Quick Ratio

Measures if Biotricity is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotricity to the Medical Devices industry mean.
  • A Quick Ratio of 0.09 means the company can pay off $0.09 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotricity Inc:

  • The MRQ is 0.089. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.155. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.089TTM0.155-0.066
TTM0.155YOY1.229-1.075
TTM0.1555Y0.768-0.614
5Y0.76810Y0.796-0.028
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0891.516-1.427
TTM0.1551.658-1.503
YOY1.2292.142-0.913
5Y0.7682.307-1.539
10Y0.7962.370-1.574

1.4. Solvency of Biotricity Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biotricity assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotricity to Medical Devices industry mean.
  • A Debt to Asset Ratio of 5.87 means that Biotricity assets are financed with 587.2% credit (debt) and the remaining percentage (100% - 587.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotricity Inc:

  • The MRQ is 5.872. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 4.866. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ5.872TTM4.866+1.006
TTM4.866YOY1.976+2.889
TTM4.8665Y3.248+1.618
5Y3.24810Y7.423-4.175
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8720.402+5.470
TTM4.8660.389+4.477
YOY1.9760.335+1.641
5Y3.2480.442+2.806
10Y7.4230.461+6.962
1.4.2. Debt to Equity Ratio

Measures if Biotricity is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotricity to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotricity Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.444-0.444
5Y0.44410Y0.498-0.054
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.559-0.559
TTM-0.560-0.560
YOY-0.479-0.479
5Y0.4440.614-0.170
10Y0.4980.674-0.176

2. Market Valuation of Biotricity Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biotricity generates.

  • Above 15 is considered overpriced but always compare Biotricity to the Medical Devices industry mean.
  • A PE ratio of -0.95 means the investor is paying $-0.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotricity Inc:

  • The EOD is -1.072. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.948. Based on the earnings, the company is expensive. -2
  • The TTM is -0.738. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.072MRQ-0.948-0.124
MRQ-0.948TTM-0.738-0.210
TTM-0.738YOY-1.569+0.831
TTM-0.7385Y-1.158+0.420
5Y-1.15810Y-2.013+0.855
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.072-1.021-0.051
MRQ-0.948-1.704+0.756
TTM-0.738-2.081+1.343
YOY-1.569-2.980+1.411
5Y-1.158-2.379+1.221
10Y-2.013-1.726-0.287
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotricity Inc:

  • The EOD is -2.304. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.038. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.372. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.304MRQ-2.038-0.266
MRQ-2.038TTM-1.372-0.666
TTM-1.372YOY-1.931+0.559
TTM-1.3725Y-1.824+0.452
5Y-1.82410Y-3.753+1.929
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.304-0.981-1.323
MRQ-2.038-1.578-0.460
TTM-1.372-2.973+1.601
YOY-1.931-6.179+4.248
5Y-1.824-4.928+3.104
10Y-3.753-5.060+1.307
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biotricity is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -0.40 means the investor is paying $-0.40 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotricity Inc:

  • The EOD is -0.450. Based on the equity, the company is expensive. -2
  • The MRQ is -0.398. Based on the equity, the company is expensive. -2
  • The TTM is -0.411. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.450MRQ-0.398-0.052
MRQ-0.398TTM-0.411+0.013
TTM-0.411YOY-15.720+15.308
TTM-0.4115Y-4.628+4.217
5Y-4.62810Y16.974-21.602
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.4501.930-2.380
MRQ-0.3982.372-2.770
TTM-0.4112.444-2.855
YOY-15.7203.205-18.925
5Y-4.6283.893-8.521
10Y16.9744.245+12.729
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biotricity Inc.

3.1. Institutions holding Biotricity Inc

Institutions are holding 3.931% of the shares of Biotricity Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc1.0890102576-144825-58.5386
2023-12-31Geode Capital Management, LLC0.680206407400
2023-12-31AE Wealth Management LLC0.44250.00024168400
2023-12-31State Street Corporation0.239402254800
2023-12-31HRT FINANCIAL LLC0.19910.000218753187530
2023-12-31BlackRock Inc0.14201337500
2023-12-31Northern Trust Corp0.127401200200
2023-12-31TD Waterhouse Canada Inc0.08490.00018000-2000-20
2023-12-31Tower Research Capital LLC0.05990.00015647247477.9704
2023-12-31PNC Financial Services Group Inc0.04020378800
2023-12-31Cedar Mountain Advisors, LLC0.02660.0008250100
2023-12-31Royal Bank of Canada0.00610570-70-10.9375
2023-12-31Wells Fargo & Co0.00320305253486.5385
2023-12-31Advisor Group Holdings, Inc.0.00220210-100-32.2581
2023-12-31Bank of America Corp0.0011099990
2023-12-31Morgan Stanley - Brokerage Accounts0.000807100
2023-12-31SIMPLEX TRADING, LLC0.0006052520
2023-12-31FMR Inc0.000201700
2023-12-31Susquehanna International Group, LLP000-30533-100
2023-12-31UBS Group AG000-1416-100
Total 3.14540.0014296272-157313-53.1%

3.2. Funds holding Biotricity Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.05320.00019972800
2024-02-29Fidelity Extended Market Index0.36820.000134865-169-0.4824
2023-09-30BlackRock Extended Mkt Composite0.14120.00021337511146500.0449
2024-03-31BlackRock Extended Equity Market K0.12330.00011167340.0343
2024-02-29Fidelity Total Market Index0.10550998600
2024-02-29Fidelity Series Total Market Index0.08450800200
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.06450.0001611200
2024-02-29Fidelity Nasdaq Composite Index0.05560526200
2023-12-31Northern Trust Extended Eq Market Idx0.05430.0001513800
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05430.0001513800
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05180.0001490990.1837
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.046304383-136567-96.8904
2024-02-29Spartan Total Market Index Pool E0.04180395600
2023-12-31SSgA U.S. Extended Market Index Class I0.0310.0001293300
2024-03-31State St US Extended Mkt Indx NL Cl C0.0310.0002293300
2024-02-29Vanguard U.S. Eq Idx £ Acc0.03010284800
2024-02-29Spartan Extended Market Index Pool E0.02080.000119681699.3941
2024-03-31Extended Equity Market Fund M0.01520.00011440-3-0.2079
2023-12-31SSgA U.S. Total Market Index Strategy0.00890846-20-2.3095
2024-02-29State St US Ttl Mkt Indx SL Cl I0.0084080000
Total 2.38990.0014226295-125431-55.4%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Biotricity Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.136-0.304+124%-0.481+254%-0.140+3%-0.080-41%
Book Value Per Share---2.887-2.577-11%-0.773-73%-0.877-70%-0.553-81%
Current Ratio--0.2110.304-31%2.123-90%1.005-79%0.807-74%
Debt To Asset Ratio--5.8724.866+21%1.976+197%3.248+81%7.423-21%
Debt To Equity Ratio----0%-0%0.444-100%0.498-100%
Dividend Per Share--0.0010.001+1%0.018-96%0.013-95%0.007-91%
Eps---0.303-0.394+30%-0.425+40%-0.428+41%-0.317+4%
Free Cash Flow Per Share---0.141-0.200+42%-0.358+154%-0.262+86%-0.185+31%
Free Cash Flow To Equity Per Share---0.120-0.012-90%-0.330+175%0.024-598%0.016-865%
Gross Profit Margin--1.0001.0000%1.039-4%1.008-1%1.126-11%
Intrinsic Value_10Y_max---0.660--------
Intrinsic Value_10Y_min---1.003--------
Intrinsic Value_1Y_max---1.078--------
Intrinsic Value_1Y_min---1.059--------
Intrinsic Value_3Y_max---2.467--------
Intrinsic Value_3Y_min---2.371--------
Intrinsic Value_5Y_max---2.927--------
Intrinsic Value_5Y_min---2.783--------
Market Cap12036648.000+12%10647804.00010167495.450+5%36085605.520-70%20550832.372-48%22902737.983-54%
Net Profit Margin---0.945-1.264+34%-2.258+139%-4.861+415%-8.318+781%
Operating Margin---0.431-0.702+63%-1.970+357%-4.546+955%-8.201+1802%
Operating Ratio--1.4311.693-15%3.128-54%5.395-73%8.713-84%
Pb Ratio-0.450-13%-0.398-0.411+3%-15.720+3846%-4.628+1062%16.974-102%
Pe Ratio-1.072-13%-0.948-0.738-22%-1.569+66%-1.158+22%-2.013+112%
Price Per Share1.300+12%1.1501.098+5%1.322-13%1.456-21%1.744-34%
Price To Free Cash Flow Ratio-2.304-13%-2.038-1.372-33%-1.931-5%-1.824-11%-3.753+84%
Price To Total Gains Ratio-9.629-13%-8.518-5.203-39%-5.042-41%-1.562-82%3.062-378%
Quick Ratio--0.0890.155-42%1.229-93%0.768-88%0.796-89%
Return On Assets---0.512-0.581+14%-0.484-5%-1.259+146%-7.899+1443%
Return On Equity----0%-0%-0.2230%-1.0490%
Total Gains Per Share---0.135-0.303+124%-0.463+243%-0.127-6%-0.073-46%
Usd Book Value---26727497.000-23863987.000-11%-7598703.750-72%-8385338.400-69%-5269147.833-80%
Usd Book Value Change Per Share---0.136-0.304+124%-0.481+254%-0.140+3%-0.080-41%
Usd Book Value Per Share---2.887-2.577-11%-0.773-73%-0.877-70%-0.553-81%
Usd Dividend Per Share--0.0010.001+1%0.018-96%0.013-95%0.007-91%
Usd Eps---0.303-0.394+30%-0.425+40%-0.428+41%-0.317+4%
Usd Free Cash Flow---1305966.000-1851597.000+42%-4285119.250+228%-2772255.050+112%-1951361.472+49%
Usd Free Cash Flow Per Share---0.141-0.200+42%-0.358+154%-0.262+86%-0.185+31%
Usd Free Cash Flow To Equity Per Share---0.120-0.012-90%-0.330+175%0.024-598%0.016-865%
Usd Market Cap12036648.000+12%10647804.00010167495.450+5%36085605.520-70%20550832.372-48%22902737.983-54%
Usd Price Per Share1.300+12%1.1501.098+5%1.322-13%1.456-21%1.744-34%
Usd Profit---2808091.000-3646010.250+30%-5108335.750+82%-4404535.100+57%-3277104.667+17%
Usd Revenue--2972972.0002906867.250+2%2284513.500+30%1550492.250+92%867497.361+243%
Usd Total Gains Per Share---0.135-0.303+124%-0.463+243%-0.127-6%-0.073-46%
 EOD+6 -2MRQTTM+22 -11YOY+18 -165Y+16 -1910Y+15 -20

4.2. Fundamental Score

Let's check the fundamental score of Biotricity Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.072
Price to Book Ratio (EOD)Between0-1-0.450
Net Profit Margin (MRQ)Greater than0-0.945
Operating Margin (MRQ)Greater than0-0.431
Quick Ratio (MRQ)Greater than10.089
Current Ratio (MRQ)Greater than10.211
Debt to Asset Ratio (MRQ)Less than15.872
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.512
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Biotricity Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.790
Ma 20Greater thanMa 501.310
Ma 50Greater thanMa 1001.240
Ma 100Greater thanMa 2001.124
OpenGreater thanClose1.410
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets5,486
Total Liabilities32,214
Total Stockholder Equity-26,727
 As reported
Total Liabilities 32,214
Total Stockholder Equity+ -26,727
Total Assets = 5,486

Assets

Total Assets5,486
Total Current Assets3,932
Long-term Assets1,554
Total Current Assets
Cash And Cash Equivalents 85
Net Receivables 1,574
Inventory 2,049
Other Current Assets 225
Total Current Assets  (as reported)3,932
Total Current Assets  (calculated)3,932
+/- 0
Long-term Assets
Property Plant Equipment 1,333
Long-term Assets Other 85
Long-term Assets  (as reported)1,554
Long-term Assets  (calculated)1,418
+/- 136

Liabilities & Shareholders' Equity

Total Current Liabilities18,619
Long-term Liabilities13,595
Total Stockholder Equity-26,727
Total Current Liabilities
Short-term Debt 10,132
Short Long Term Debt 9,722
Accounts payable 4,656
Other Current Liabilities 3,820
Total Current Liabilities  (as reported)18,619
Total Current Liabilities  (calculated)28,330
+/- 9,711
Long-term Liabilities
Long term Debt 11,404
Capital Lease Obligations 1,461
Long-term Liabilities  (as reported)13,595
Long-term Liabilities  (calculated)12,865
+/- 730
Total Stockholder Equity
Common Stock9
Retained Earnings -123,100
Other Stockholders Equity 95,561
Total Stockholder Equity (as reported)-26,727
Total Stockholder Equity (calculated)-27,529
+/- 802
Other
Capital Stock1,038
Cash and Short Term Investments 85
Common Stock Shares Outstanding 8,979
Current Deferred Revenue11
Liabilities and Stockholders Equity 5,486
Net Debt 22,502
Net Invested Capital -6,630
Net Working Capital -14,686
Property Plant and Equipment Gross 1,346
Short Long Term Debt Total 22,587



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
> Total Assets 
0
0
0
520
28
28
19
519
159
110
84
68
474
1,242
667
2,573
929
929
419
473
491
491
1,058
5,529
2,004
2,004
2,068
5,140
4,438
2,767
13,952
21,045
16,678
16,678
8,053
6,647
6,511
6,144
6,824
5,486
5,4866,8246,1446,5116,6478,05316,67816,67821,04513,9522,7674,4385,1402,0682,0042,0045,5291,0584914914734199299292,5736671,2424746884110159519192828520000
   > Total Current Assets 
0
0
0
520
1
1
19
486
159
110
84
35
441
1,209
634
2,540
896
896
386
440
458
458
661
5,182
1,659
1,659
1,828
4,942
4,322
2,745
13,946
19,610
15,323
15,323
6,752
4,794
4,720
4,401
5,178
3,932
3,9325,1784,4014,7204,7946,75215,32315,32319,61013,9462,7454,3224,9421,8281,6591,6595,1826614584584403868968962,5406341,20944135841101594861911520000
       Cash And Cash Equivalents 
0
0
0
449
0
-449
4
411
54
34
24
21
425
1,193
607
2,482
844
844
83
26
64
64
43
4,354
950
950
470
3,324
2,202
202
11,694
16,790
12,067
12,067
2,498
451
570
51
1,200
85
851,200515704512,49812,06712,06716,79011,6942022,2023,3244709509504,35443646426838448442,4826071,193425212434544114-4490449000
       Short-term Investments 
0
0
0
0
0
897
0
0
0
0
0
4
0
8
7
30
17
5
29
109
101
63
30
29
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000293063101109295173078040000089700000
       Net Receivables 
0
0
0
0
0
75
75
75
106
76
60
14
16
16
27
58
36
53
95
180
208
369
586
730
486
623
1,180
1,523
1,848
2,363
2,134
2,460
2,111
2,413
2,400
2,411
1,813
2,134
1,850
1,574
1,5741,8502,1341,8132,4112,4002,4132,1112,4602,1342,3631,8481,5231,1806234867305863692081809553365827161614607610675757500000
       Other Current Assets 
0
0
0
0
0
1
14
0
0
0
0
0
0
16
27
58
0
17
29
109
0
101
30
63
0
0
-2
0
327
413
491
471
0
381
392
436
589
621
240
225
22524062158943639238104714914133270-200633010101092917058271600000014100000
   > Long-term Assets 
0
0
0
0
27
27
27
33
0
33
0
33
33
33
33
33
0
33
33
33
33
33
397
347
346
346
238
197
116
23
6
1,436
1,355
1,355
1,301
1,853
1,790
1,743
1,646
1,554
1,5541,6461,7431,7901,8531,3011,3551,3551,4366231161972383463463473973333333333033333333330330332727270000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
413
364
314
264
264
165
116
66
1,400
0
1,400
1,270
1,270
1,165
1,696
1,609
1,520
1,428
1,333
1,3331,4281,5201,6091,6961,1651,2701,2701,40001,40066116165264264314364413000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
33
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
3
0
0
0
0
0
0
0
0
00000000360000000000000000003300000000000
       Other Assets 
0
0
0
0
0
0
-27
0
106
-33
60
-33
0
33
33
33
33
33
33
33
33
33
33
33
81
50
2
82
50
23
6
36
85
85
0
157
0
0
0
0
0000157085853662350822508133333333333333333333330-3360-331060-27000000
> Total Liabilities 
0
171
0
176
262
262
262
1,758
2,729
3,779
2,597
4,136
4,858
4,782
763
630
756
756
1,048
1,324
2,268
2,268
5,956
7,442
5,005
5,005
9,481
15,847
11,271
13,367
6,207
18,726
18,823
18,823
18,677
22,129
26,356
29,556
32,295
32,214
32,21432,29529,55626,35622,12918,67718,82318,82318,7266,20713,36711,27115,8479,4815,0055,0057,4425,9562,2682,2681,3241,0487567566307634,7824,8584,1362,5973,7792,7291,75826226226217601710
   > Total Current Liabilities 
0
171
0
176
262
262
262
1,758
695
1,778
2,597
4,136
4,858
4,782
763
630
756
756
1,048
1,324
2,268
2,268
5,789
6,538
3,803
3,803
7,106
8,443
10,490
12,290
5,215
4,829
4,867
4,867
4,389
7,291
11,161
15,098
17,824
18,619
18,61917,82415,09811,1617,2914,3894,8674,8674,8295,21512,29010,4908,4437,1063,8033,8036,5385,7892,2682,2681,3241,0487567566307634,7824,8584,1362,5971,7786951,75826226226217601710
       Short-term Debt 
0
20
0
0
0
46
34
784
156
624
724
1,309
1,557
0
0
0
0
18
0
18
868
868
3,843
4,468
0
2,281
2,588
5,810
4,336
5,595
1,831
1,340
0
1,750
1,366
3,449
5,110
6,550
8,282
10,132
10,1328,2826,5505,1103,4491,3661,75001,3401,8315,5954,3365,8102,5882,28104,4683,8438688681801800001,5571,3097246241567843446000200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
178
1,155
1,837
2,820
0
0
0
0
0
0
0
0
868
2,183
3,643
4,262
2,068
1,871
2,420
5,696
4,278
5,595
1,831
1,138
1,540
1,238
1,138
3,126
4,774
6,200
7,918
9,722
9,7227,9186,2004,7743,1261,1381,2381,5401,1381,8315,5954,2785,6962,4201,8712,0684,2623,6432,183868000000002,8201,8371,15517800000000
       Accounts payable 
0
120
0
131
0
172
181
274
448
583
629
824
866
583
625
518
386
548
817
972
878
878
1,216
1,246
1,094
1,094
1,295
1,479
1,041
1,283
1,623
1,429
1,159
1,159
1,227
2,384
3,435
4,174
4,530
4,656
4,6564,5304,1743,4352,3841,2271,1591,1591,4291,6231,2831,0411,4791,2951,0941,0941,2461,216878878972817548386518625583866824629583448274181172013101200
       Other Current Liabilities 
0
30
0
45
0
44
48
700
91
571
1,245
1,849
2,435
4,199
138
112
0
208
231
334
0
522
729
824
0
428
3,223
1,155
5,113
5,411
1,761
2,060
521
1,957
387
352
1,008
1,985
5,004
3,820
3,8205,0041,9851,0083523871,9575212,0601,7615,4115,1131,1553,2234280824729522033423120801121384,1992,4351,8491,2455719170048440450300
   > Long-term Liabilities 
0
120
0
0
0
181
172
0
2,035
2,001
1,353
2,001
2,423
518
625
583
0
548
817
671
0
220
167
904
1,202
1,202
2,374
7,404
781
1,077
993
13,898
13,956
13,956
14,288
14,838
15,195
14,458
14,471
13,595
13,59514,47114,45815,19514,83814,28813,95613,95613,8989931,0777817,4042,3741,2021,202904167220067181754805836255182,4232,0011,3532,0012,03501721810001200
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
871
12,434
0
0
0
0
0
0
0
0
0000000012,434871000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
287
352
537
702
0
0
0
0
0
000007025373522870000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,833
410
410
122
287
0
0
0
0
0
0
0
0
000000002871224104105,833000000000000000000000000000
> Total Stockholder Equity
0
-171
0
-83
0
-234
-244
-1,239
-2,570
-3,670
-2,513
-4,069
-4,385
-3,540
-95
1,943
173
173
-628
-851
-1,778
-1,778
-4,898
-1,913
-3,000
-3,000
-7,413
-10,708
-6,833
-10,600
7,745
2,319
-2,145
-2,145
-10,624
-15,482
-19,845
-23,412
-25,471
-26,727
-26,727-25,471-23,412-19,845-15,482-10,624-2,145-2,1452,3197,745-10,600-6,833-10,708-7,413-3,000-3,000-1,913-4,898-1,778-1,778-851-6281731731,943-95-3,540-4,385-4,069-2,513-3,670-2,570-1,239-244-2340-830-1710
   Common Stock
0
5
0
3,960
0
5
9
25
25
25
26
26
27
30
31
32
32
32
33
34
35
35
36
36
36
36
37
38
39
39
49
50
51
51
52
52
53
53
9
9
99535352525151504939393837363636363535343332323231302726262525259503,960050
   Retained Earnings Total Equity00000000-87,055-79,713-62,818-62,818-57,033000000000000000000000000000
   Accumulated Other Comprehensive Income -227-47-329-153-143-70-7690-636-616-628-634-670-1,037-8570-1,029-794-7550-411-633-6430-629-584-500-413-265-289-148-80-18-18-1800000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,707
56,299
56,299
84,894
85,874
0
0
0
0
0
0
0
0
0000000085,87484,89456,29956,29946,707000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
83
0
7,983
13
15,965
15,965
15,991
23,269
25,359
28,617
35,081
44,079
52,392
-573
54,464
62,032
65,485
-663
67,963
69,994
81,224
-688
88,370
93,002
93,916
113,159
117,407
176,050
179,922
-666
183,220
92,360
92,322
92,826
93,037
93,363
95,561
95,56193,36393,03792,82692,32292,360183,220-666179,922176,050117,407113,15993,91693,00288,370-68881,22469,99467,963-66365,48562,03254,464-57352,39244,07935,08128,61725,35923,26915,99115,96515,965137,983083000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue9,639
Cost of Revenue-4,197
Gross Profit5,4425,442
 
Operating Income (+$)
Gross Profit5,442
Operating Expense-20,852
Operating Income-15,592-15,410
 
Operating Expense (+$)
Research Development3,230
Selling General Administrative17,622
Selling And Marketing Expenses0
Operating Expense20,85220,852
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,583
Other Finance Cost-0
Net Interest Income-2,583
 
Pretax Income (+$)
Operating Income-15,592
Net Interest Income-2,583
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-18,658-14,926
EBIT - interestExpense = -18,174
-16,257
-16,076
Interest Expense2,583
Earnings Before Interest and Taxes (EBIT)-15,592-16,076
Earnings Before Interest and Taxes (EBITDA)-15,586
 
After tax Income (+$)
Income Before Tax-18,658
Tax Provision-0
Net Income From Continuing Ops-18,658-18,658
Net Income-18,658
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses25,049
Total Other Income/Expenses Net-6662,583
 

Technical Analysis of Biotricity
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biotricity. The general trend of Biotricity is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biotricity's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biotricity Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.65 < 1.67 < 1.9.

The bearish price targets are: 1.12 > 1.12 > 1.12.

Tweet this
Biotricity Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biotricity Inc. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biotricity Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biotricity Inc. The current macd is 0.03355341.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biotricity price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biotricity. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biotricity price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Biotricity Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiotricity Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biotricity Inc. The current adx is 23.88.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biotricity shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Biotricity Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biotricity Inc. The current sar is 1.2047401.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Biotricity Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biotricity Inc. The current rsi is 49.79. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Biotricity Inc Daily Relative Strength Index (RSI) ChartBiotricity Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biotricity Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biotricity price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Biotricity Inc Daily Stochastic Oscillator ChartBiotricity Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biotricity Inc. The current cci is 11.40.

Biotricity Inc Daily Commodity Channel Index (CCI) ChartBiotricity Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biotricity Inc. The current cmo is -4.06580955.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biotricity Inc Daily Chande Momentum Oscillator (CMO) ChartBiotricity Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biotricity Inc. The current willr is -62.5.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biotricity is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biotricity Inc Daily Williams %R ChartBiotricity Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biotricity Inc.

Biotricity Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biotricity Inc. The current atr is 0.17719284.

Biotricity Inc Daily Average True Range (ATR) ChartBiotricity Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biotricity Inc. The current obv is 2,758,453.

Biotricity Inc Daily On-Balance Volume (OBV) ChartBiotricity Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biotricity Inc. The current mfi is 60.62.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Biotricity Inc Daily Money Flow Index (MFI) ChartBiotricity Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biotricity Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Biotricity Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biotricity Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.790
Ma 20Greater thanMa 501.310
Ma 50Greater thanMa 1001.240
Ma 100Greater thanMa 2001.124
OpenGreater thanClose1.410
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biotricity with someone you think should read this too:
  • Are you bullish or bearish on Biotricity? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biotricity? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biotricity Inc

I send you an email if I find something interesting about Biotricity Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biotricity Inc.

Receive notifications about Biotricity Inc in your mailbox!